Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Darexaban

Darexaban
Darexaban (Tanexaban, YM-150) is a direct inhibitor of Factor Xa.Darexaban and Darexaban glucuronide selectively and competitively inhibit FXA and inhibit prothrombin activity at the site of blood clot (thrombus) formation. This leads to a reduction in blood clot formation in a dose-dependent manner. Reducing clotting will reduce blockages in blood flow, which may reduce the risk of myocardial infarction, unstable angina, venous thrombosis, and ischemic stroke.
Catalog No. T31206Cas No. 365462-23-3
Select Batch
Purity:98.33%
Contact us for more batch information
Resource Download

Darexaban

Catalog No. T31206Cas No. 365462-23-3
Darexaban (Tanexaban, YM-150) is a direct inhibitor of Factor Xa.Darexaban and Darexaban glucuronide selectively and competitively inhibit FXA and inhibit prothrombin activity at the site of blood clot (thrombus) formation. This leads to a reduction in blood clot formation in a dose-dependent manner. Reducing clotting will reduce blockages in blood flow, which may reduce the risk of myocardial infarction, unstable angina, venous thrombosis, and ischemic stroke.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
1 mg$40In Stock
2 mg$57In Stock
5 mg$87In Stock
10 mg$147In Stock
25 mg$296In Stock
50 mg$482In Stock
100 mg$689In Stock
1 mL x 10 mM (in DMSO)$93In Stock
Bulk & Custom
Add to Cart

Related Compound Libraries of "Darexaban"

Product Introduction

Bioactivity
Description
Darexaban (Tanexaban, YM-150) is a direct inhibitor of Factor Xa.Darexaban and Darexaban glucuronide selectively and competitively inhibit FXA and inhibit prothrombin activity at the site of blood clot (thrombus) formation. This leads to a reduction in blood clot formation in a dose-dependent manner. Reducing clotting will reduce blockages in blood flow, which may reduce the risk of myocardial infarction, unstable angina, venous thrombosis, and ischemic stroke.
Targets&IC50
FXa:54.6 nM
AliasYM 150, Darexaban, Tanexaban, YM150
Chemical Properties
Molecular Weight474.55
FormulaC27H30N4O4
Cas No.365462-23-3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 245 mg/mL (516.28 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.1073 mL10.5363 mL21.0726 mL105.3630 mL
5 mM0.4215 mL2.1073 mL4.2145 mL21.0726 mL
10 mM0.2107 mL1.0536 mL2.1073 mL10.5363 mL
20 mM0.1054 mL0.5268 mL1.0536 mL5.2681 mL
50 mM0.0421 mL0.2107 mL0.4215 mL2.1073 mL
100 mM0.0211 mL0.1054 mL0.2107 mL1.0536 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Darexaban | purchase Darexaban | Darexaban cost | order Darexaban | Darexaban chemical structure | Darexaban formula | Darexaban molecular weight